An evaluation of toxicity and outcomes in West of Scotland patients receiving second line treatment of non-small cell lung cancer

被引：0
|
作者：
Laskey, J. [1 ]
MacLean, F. [1 ]
机构：
[1] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70015-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] The use of second or third line nivolumab in advanced non-small cell lung cancer: a west of Scotland experience
    Ali, C.
    Yahya, K.
    [J]. LUNG CANCER, 2018, 115 : S31 - S31
  • [2] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer
    Scagliotti, G
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2855 - 2866
  • [3] Second and third line treatment in non-small cell lung cancer
    Favaretto, Adolfo
    Pasello, Giulia
    Magro, Cristina
    Schettino, Clorinda
    Gridelli, Cesare
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (02) : 117 - 126
  • [4] Evaluation of second-line treatment options in non-small cell lung cancer - Introduction
    Scagliotti, GV
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S1 - S2
  • [5] Second line treatment of non-small cell lung cancer with paclitaxel and gemcitabine
    Kakolyris, S
    Kourousis, C
    Androulakis, N
    Dimopoulos, MA
    Papadakis, E
    Tzannes, S
    Kotsakis, T
    Vardakis, N
    Merambeliotakis, N
    Kalbakis, C
    Xatzidaki, D
    Georgoulias, V
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1049 - 1049
  • [6] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [7] Evaluation and Treatment of Patients with Non-Small Cell Lung Cancer
    Carr, Laurie L.
    Finigan, James H.
    Kern, Jeffrey A.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (06) : 1041 - +
  • [8] Pemetrexed in second line of non-small cell lung cancer
    Earata, Fernando
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2008, 14 : S21 - S26
  • [9] Treatment patterns and outcomes in patients with non-squamous advanced non-small cell lung cancer receiving second-line treatment in a community-based oncology network
    Pan, I. W.
    Mallick, R.
    Dhanda, R.
    Nadler, E.
    [J]. LUNG CANCER, 2013, 82 (03) : 469 - 476
  • [10] Influence of Radiotherapy in Second-Line Treatment with Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Azkona, E.
    Carrera, S.
    Rubio, I.
    Mane, J. M.
    Lacambra, I.
    Sancho, A.
    Novo, E.
    Lopez-Vivanco, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S969 - S969
12345